Pharma in Focus - knowledge in power
6 - 12 Feb 2012
 
Analysis: Anticoagulants in the PBS spotlight
Professor Lloyd Sansom's review of anticoagulant therapies - better known as the Pradaxa review - will soon get underway with submissions due to close this month. What does it presage for the future operation of the PBS?
Pharma's two faces on display
Today's Pharma in Focus shows two faces of pharma. One we've unfortunately grown used to over recent years, the regular announcement of job cuts, but the other is more encouraging
Subscribe to Pharma in Focus

Sign Up Now

What you'll pay

A two week trial of Pharma in Focus is FREE of charge.

Annual subscription to Pharma in Focus costs $379.95.

24 hour subscription to Pharma in Focus costs $9.95.

Special rates for groups of five or more are also available.
For further information, contact our sales department on 02 9939 1881

3 Simple Steps

Fill in your details below and submit
Make your subscription choice
Make your payment choice (Credit Card, Direct Deposit or Cheque)

Email Address
Retype your Email Address
First Name
Last name
Company or Organisation
Position
Phone
Send me News Alerts as
 HTML (colourful) OR Text only
 

Note: When your subscription has expired we hope you will renew it but we will continue to send you the daily Pharma in Focus News Alert whether you renew or not. You can unsubscribe from this service at any time.

Access: Full text access is immediate upon email verification.

Privacy policy: The list on which your email address appears is protected and will not be sold or passed on to any other organisation or individual.

TOP | BACK

 
 
AZ staff await job cut news
..full report
GSK expands local manufacturing
..full report
Sandoz steers clear of Crestor fight
..full report
Fall in per capita PBS spend
..full report
Sanofi's Lyxumia on approval track
..full report
Party donations top $400K
..full report
Latest ARTG registrations
..full report
© 2007 Lush Media | Privacy Statement | Subscribe to Pharma in Focus